Stephen Pawsey
Keine laufenden Positionen mehr
Profil
Stephen Pawsey worked as a Development Director at Ligand UK Ltd., Chief Medical Officer at Circassia Ltd., Vice President-Development & Medical Affairs at Pharmagene Plc, and Chief Medical Officer at Niox Group Plc.
He holds a doctorate degree from the University of London.
Ehemalige bekannte Positionen von Stephen Pawsey
| Unternehmen | Position | Ende |
|---|---|---|
| NIOX GROUP PLC | Technik-/Wissenschafts-/F&E-Leiter | - |
| Pharmagene Plc | Technik-/Wissenschafts-/F&E-Leiter | - |
Circassia Ltd.
 Circassia Ltd. Pharmaceuticals: OtherHealth Technology Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | - |
| VERNALIS | Corporate Officer/Principal | - |
Ausbildung von Stephen Pawsey
| University of London | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NIOX GROUP PLC | Health Services |
| Private Unternehmen | 3 |
|---|---|
Ligand UK Ltd.
 Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1988 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
| Pharmagene Plc | Health Technology |
Circassia Ltd.
Circassia Ltd. Pharmaceuticals: OtherHealth Technology Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom. | Health Technology |
